After Plunging 8.7% in 4 Weeks, Here's Why the Trend Might Reverse for ResMed (RMD)

Core Viewpoint - ResMed (RMD) has faced significant selling pressure, resulting in an 8.7% decline over the past four weeks, but analysts anticipate improved earnings in the near future [1]. Group 1: Technical Analysis - The Relative Strength Index (RSI) is utilized to determine if a stock is oversold, with a reading below 30 indicating oversold conditions [2]. - RMD's current RSI reading is 28.12, suggesting that the heavy selling may be nearing exhaustion, potentially leading to a price rebound [5]. Group 2: Fundamental Analysis - Analysts have raised earnings estimates for RMD, with a 0.1% increase in the consensus EPS estimate over the last 30 days, indicating a positive trend that often correlates with price appreciation [7]. - RMD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, further supporting the potential for a turnaround [8].